📊 Score Breakdown
Offering Ability
20
Cash Runway
0
Float Risk
7
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for ACVA.
💹 Market Data
Market Cap$1.10B
Shares Outstanding174.58M
Float159.12M
Cash$340.97M
Debt$246.00M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↓ 10.7% shares (2025Q4 vs prior)
262 institutional holders · 171.08M shares
#1
VANGUARD GROUP INC
15.52M shares
#2
BlackRock, Inc.
13.04M shares
#3
Atreides Management, LP
12.41M shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest11.29M
Days to Cover4.7
% of Float7.1%
FINRA data as of Apr 30, 2026
📁 Recent SEC Activity
xbrl
XBRL CONVERTIBLE
Dec 31, 2021
4
INSIDER TRANSACTION
Apr 03, 2026
4
INSIDER TRANSACTION
Apr 03, 2026
4
INSIDER TRANSACTION
Apr 03, 2026
4
INSIDER TRANSACTION
Apr 03, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for ACVA
📊 ACVA FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 ACVA Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.